The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study
Background: Vaccination is the most remarkable intervention in public health and is an effective strategy in controlling infectious diseases among infants. Objectives: The aim of this study was to compare the adverse events of Pentavalent vaccine and DPT vaccine in two- to six-month-old infants in I...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Ubiquity Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/652a60ef47c04953916169d133edbede |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:652a60ef47c04953916169d133edbede |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:652a60ef47c04953916169d133edbede2021-12-02T11:37:53ZThe Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study2214-999610.5334/aogh.2449https://doaj.org/article/652a60ef47c04953916169d133edbede2020-02-01T00:00:00Zhttps://annalsofglobalhealth.org/articles/2449https://doaj.org/toc/2214-9996Background: Vaccination is the most remarkable intervention in public health and is an effective strategy in controlling infectious diseases among infants. Objectives: The aim of this study was to compare the adverse events of Pentavalent vaccine and DPT vaccine in two- to six-month-old infants in Iran. Methods: This is an analytical cross-sectional study in which healthy infants aged two to six months, having received DPT vaccine in 2013 and Pentavalent vaccine in 2015, were studied for any experienced adverse events related to these vaccines. Percentage, mean, standard deviation and chi-square tests were used to describe and analyze the data (p < 0.05). Findings: The results showed that 10,464 and 17,561 adverse events, which were associated with DPT vaccine and Pentavalent vaccine respectively, were recorded in the infants who received these vaccines throughout Iran. Mazandaran, Qazvin and Golestan provinces reported the highest number of adverse events, respectively (15.74%, 11.25%, and 9.12%). Moreover, Pentavalent vaccine seemed to have more recorded adverse events compared to DPT, high fever had the highest record rate for DPT vaccine (47.4%) and mild localized complications was the highest for Pentavalent vaccines (31.68%). There was a significant relationship between the kind of vaccine and the type of reaction, adverse event categorization and the country that produced the vaccine (p < 0.05). Conclusion: Severe localized adverse events including high fever, vomiting, diarrhea and restlessness seemed to be less in Pentavalent vaccine compared to DPT vaccine. Therefore, substituting Pentavalent vaccine for DPT vaccine in infants seems to reduce the adverse events among them.Zaher KhazaeiGhobad MoradiSeyed Mohsen ZahraeiMohammad Mehdi GouyaElham GoodarziFateme YaghiniDaem RoshaniUbiquity PressarticleInfectious and parasitic diseasesRC109-216Public aspects of medicineRA1-1270ENAnnals of Global Health, Vol 86, Iss 1 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Infectious and parasitic diseases RC109-216 Public aspects of medicine RA1-1270 |
spellingShingle |
Infectious and parasitic diseases RC109-216 Public aspects of medicine RA1-1270 Zaher Khazaei Ghobad Moradi Seyed Mohsen Zahraei Mohammad Mehdi Gouya Elham Goodarzi Fateme Yaghini Daem Roshani The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study |
description |
Background: Vaccination is the most remarkable intervention in public health and is an effective strategy in controlling infectious diseases among infants. Objectives: The aim of this study was to compare the adverse events of Pentavalent vaccine and DPT vaccine in two- to six-month-old infants in Iran. Methods: This is an analytical cross-sectional study in which healthy infants aged two to six months, having received DPT vaccine in 2013 and Pentavalent vaccine in 2015, were studied for any experienced adverse events related to these vaccines. Percentage, mean, standard deviation and chi-square tests were used to describe and analyze the data (p < 0.05). Findings: The results showed that 10,464 and 17,561 adverse events, which were associated with DPT vaccine and Pentavalent vaccine respectively, were recorded in the infants who received these vaccines throughout Iran. Mazandaran, Qazvin and Golestan provinces reported the highest number of adverse events, respectively (15.74%, 11.25%, and 9.12%). Moreover, Pentavalent vaccine seemed to have more recorded adverse events compared to DPT, high fever had the highest record rate for DPT vaccine (47.4%) and mild localized complications was the highest for Pentavalent vaccines (31.68%). There was a significant relationship between the kind of vaccine and the type of reaction, adverse event categorization and the country that produced the vaccine (p < 0.05). Conclusion: Severe localized adverse events including high fever, vomiting, diarrhea and restlessness seemed to be less in Pentavalent vaccine compared to DPT vaccine. Therefore, substituting Pentavalent vaccine for DPT vaccine in infants seems to reduce the adverse events among them. |
format |
article |
author |
Zaher Khazaei Ghobad Moradi Seyed Mohsen Zahraei Mohammad Mehdi Gouya Elham Goodarzi Fateme Yaghini Daem Roshani |
author_facet |
Zaher Khazaei Ghobad Moradi Seyed Mohsen Zahraei Mohammad Mehdi Gouya Elham Goodarzi Fateme Yaghini Daem Roshani |
author_sort |
Zaher Khazaei |
title |
The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study |
title_short |
The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study |
title_full |
The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study |
title_fullStr |
The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study |
title_full_unstemmed |
The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study |
title_sort |
comparison of the adverse events of pentavalent vaccine and dpt vaccine in 2–6 months infants in iran: a national study |
publisher |
Ubiquity Press |
publishDate |
2020 |
url |
https://doaj.org/article/652a60ef47c04953916169d133edbede |
work_keys_str_mv |
AT zaherkhazaei thecomparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy AT ghobadmoradi thecomparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy AT seyedmohsenzahraei thecomparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy AT mohammadmehdigouya thecomparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy AT elhamgoodarzi thecomparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy AT fatemeyaghini thecomparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy AT daemroshani thecomparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy AT zaherkhazaei comparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy AT ghobadmoradi comparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy AT seyedmohsenzahraei comparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy AT mohammadmehdigouya comparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy AT elhamgoodarzi comparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy AT fatemeyaghini comparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy AT daemroshani comparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy |
_version_ |
1718395762968100864 |